Brain Tumor Res Treat.  2019 Oct;7(2):147-150. 10.14791/btrt.2019.7.e40.

A Case of Sporadic Suprasellar Hemangioblastoma Mimicking Meningioma

Affiliations
  • 1Department of Neurosurgery, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Korea. smyoun@kirams.re.kr

Abstract

Hemangioblastoma (HBL) in the suprasellar region is very rare and a few cases have been reported. Suprasellar HBL without von Hippel-Lindau disease is much rarer. A 76-year old male patient presented progressively deteriorating visual disturbance. MRI demonstrated solid suprasellar mass of 20 mm in diameter, broadly based to planum sphenoidale and diaphragm sella and dural tail sign after the administration of gadolinium diethylene triamine penta-acetic acid (Gd-DTPA). Preoperative diagnosis was meningioma. Total resection of the tumor was not accomplished because of massive hemorrhage, and the histopathologic examination revealed the tumor to be HBL. The visual disturbance of the patient was not improved. The authors reviewed the literature and considered a differential diagnosis of suprasellar tumors and treatment of suprasellar HBL.

Keyword

Hemangioblastoma; Suprasellar; von Hippel Lindau disease

MeSH Terms

Diagnosis
Diagnosis, Differential
Diaphragm
Gadolinium
Hemangioblastoma*
Hemorrhage
Humans
Magnetic Resonance Imaging
Male
Meningioma*
Tail
Temazepam
von Hippel-Lindau Disease
Gadolinium
Temazepam

Figure

  • Fig. 1 Preoperative axial MRI without contrast enhancement showing isointense on T1-weighted image and hyperintense on T2-weighted image suprasellar mass of 20 mm in diameter (A and B). Sagittal and coronal image with contrast enhancement demonstrated homogeneously enhancing solid mass broadly based to planum sphenoidale and diaphragm sella and strong dural tail sign (arrow) (C and D).

  • Fig. 2 Hematoxylin and eosin staining showing two different components characterized by numerous thin walled capillary vessels and stromal cells, which are characteristically clear and vacuolated cytoplasm were seen in low and high magnification [×200 (A), ×400 (B)]. Immunostaining for CD34 highlighted the rich vascular network (C) and stromal cells showed immunoreactivity for neuron specific enolase (D).


Reference

1. Browne TR, Adams RD, Roberson GH. Hemangioblastoma of the spinal cord. Review and report of five cases. Arch Neurol. 1976; 33:435–441.
2. Conway JE, Chou D, Clatterbuck RE, Brem H, Long DM, Rigamonti D. Hemangioblastomas of the central nervous system in von Hippel-Lindau syndrome and sporadic disease. Neurosurgery. 2001; 48:55–62. discussion 62-3.
Article
3. Constans JP, Meder F, Maiuri F, Donzelli R, Spaziante R, de Divitiis E. Posterior fossa hemangioblastomas. Surg Neurol. 1986; 25:269–275.
Article
4. Neumann HP, Eggert HR, Weigel K, Friedburg H, Wiestler OD, Schollmeyer P. Hemangioblastomas of the central nervous system. A 10-year study with special reference to von Hippel-Lindau syndrome. J Neurosurg. 1989; 70:24–30.
5. Wanebo JE, Lonser RR, Glenn GM, Oldfield EH. The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease. J Neurosurg. 2003; 98:82–94.
Article
6. Lonser RR, Butman JA, Huntoon K, et al. Prospective natural history study of central nervous system hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2014; 120:1055–1062.
Article
7. Lonser RR, Butman JA, Kiringoda R, Song D, Oldfield EH. Pituitary stalk hemangioblastomas in von Hippel-Lindau disease. J Neurosurg. 2009; 110:350–353.
Article
8. Mills SA, Oh MC, Rutkowski MJ, Sughrue ME, Barani IJ, Parsa AT. Supratentorial hemangioblastoma: clinical features, prognosis, and predictive value of location for von Hippel-Lindau disease. Neuro Oncol. 2012; 14:1097–1104.
Article
9. Miyata S, Mikami T, Minamida Y, Akiyama Y, Houkin K. Suprasellar hemangioblastoma. J Neuroophthalmol. 2008; 28:325–326.
Article
10. Peker S, Kurtkaya-Yapicier O, Sun I, Sav A, Pamir MN. Suprasellar haemangioblastoma. Report of two cases and review of the literature. J Clin Neurosci. 2005; 12:85–89.
Article
11. Li Z, Feng T, Teng H, Hu Y, Yao Y, Liu Y. Suprasellar hemangioblastoma without von Hippel-Lindau disease: a case report and literature review. Int J Clin Exp Pathol. 2015; 8:7553–7558.
12. Lee GI, Kim JM, Choi KS, Kim CH. Sporadic hemangioblastoma in the pituitary stalk: a case report and review of the literature. J Korean Neurosurg Soc. 2015; 57:465–468.
Article
13. Sawin PD, Follett KA, Wen BC, Laws ER Jr. Symptomatic intrasellar hemangioblastoma in a child treated with subtotal resection and adjuvant radiosurgery. J Neurosurg. 1996; 84:1046–1050.
Article
14. Xie T, Zhang X, Hu F, et al. Suprasellar hemangioblastoma mimicking a craniopharyngioma: result of extended endoscopic transsphenoidal approach--case report. Neurol Med Chir (Tokyo). 2013; 53:735–739.
Article
15. Grisoli F, Gambarelli D, Raybaud C, Guibout M, Leclercq T. Suprasellar hemangioblastoma. Surg Neurol. 1984; 22:257–262.
Article
16. Ikeda M, Asada M, Yamashita H, Ishikawa A, Tamaki N. [A case of suprasellar hemangioblastoma with thoracic meningioma]. No Shinkei Geka. 2001; 29:679–683.
17. Rumboldt Z, Gnjidić Z, Talan-Hranilović J, Vrkljan M. Intrasellar hemangioblastoma: characteristic prominent vessels on MR imaging. AJR Am J Roentgenol. 2003; 180:1480–1481.
Article
Full Text Links
  • BTRT
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr